Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Contact
Home
Investors
SEC Filings
All SEC Filings
All SEC Filings
Filter Filings:
View All
10-K
10-K/A
10-Q
15-12G
3
4
4/A
424B3
424B4
424B5
8-A12G
8-K
8-K/A
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFR14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
RW
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
02/25/21
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
02/16/21
424B3
Prospectus filed pursuant to Rule 424(b)(3)
83
02/16/21
424B3
Prospectus filed pursuant to Rule 424(b)(3)
83
02/12/21
8-K
Current report filing
Related Documents
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-99.1
50
02/12/21
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
36
02/08/21
424B3
Prospectus filed pursuant to Rule 424(b)(3)
66
02/08/21
424B3
Prospectus filed pursuant to Rule 424(b)(3)
62
01/29/21
EFFECT
Notice of Effectiveness
1
01/26/21
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Related Documents
EX-10.62
EX-23.1
139
01/22/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
<< Previous
1...
14
15
16
17
18
19
20
21
22
23
...56
Next >>